Response to Concerns about Making Markets for Vaccines

The authors of Making Markets for Vaccines respond here to issues raised in the CIPIH Discussion Forum and elsewhere.

The development of drugs and vaccines for affluent countries has been achieved by a combination of publicly funded research and commercial investment based on anticipated markets for the final product, and this combination has produced a range of drugs and vaccines which have transformed the lives of people in rich countries over the last century. By contrast, there are very few examples of successful pharmaceutical development based solely on public funding, without any contribution from commercial investment by the private sector.